Perspectum
Perspectum provides non-invasive, quantitative imaging solutions that extract biomarkers from MRI scans to assist in the diagnosis and management of metabolic, liver, and multi-organ diseases. Their technology, including products like LiverMultiScan and CoverScan, serves clinicians, pharmaceutical companies, and researchers by providing data intelligence for drug development and personalized patient care. The company focuses on chronic conditions such as MASLD/MASH, autoimmune diseases, and oncology.
Healthtech
Medical Technology
Diagnostics
Precision Health
Funding summary
- Total raised
- €85.1M
- Funding rounds
- 3
Investors in Perspectum
Investors on record for Perspectum. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Perspectum?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors